IRIS
GITTO, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.990
EU - Europa 13.374
AS - Asia 6.625
SA - Sud America 2.170
AF - Africa 195
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 42.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.745
RU - Federazione Russa 7.072
SG - Singapore 2.818
BR - Brasile 1.873
CN - Cina 1.646
IE - Irlanda 1.569
SE - Svezia 1.335
IT - Italia 678
VN - Vietnam 673
UA - Ucraina 611
HK - Hong Kong 605
DE - Germania 573
GB - Regno Unito 384
FR - Francia 376
FI - Finlandia 313
IN - India 301
CA - Canada 119
AR - Argentina 107
BD - Bangladesh 90
PL - Polonia 74
MX - Messico 70
IQ - Iraq 67
JP - Giappone 64
CZ - Repubblica Ceca 61
NL - Olanda 60
BE - Belgio 58
AT - Austria 53
ZA - Sudafrica 52
TR - Turchia 51
EC - Ecuador 48
MA - Marocco 47
UZ - Uzbekistan 38
CI - Costa d'Avorio 33
ES - Italia 31
CO - Colombia 28
ID - Indonesia 28
CL - Cile 26
VE - Venezuela 26
PK - Pakistan 25
PY - Paraguay 21
SA - Arabia Saudita 20
UY - Uruguay 17
JO - Giordania 16
AE - Emirati Arabi Uniti 15
EG - Egitto 15
GR - Grecia 15
IR - Iran 15
AZ - Azerbaigian 14
PH - Filippine 14
PE - Perù 13
LT - Lituania 12
LV - Lettonia 12
MY - Malesia 12
OM - Oman 12
NO - Norvegia 11
AL - Albania 10
BO - Bolivia 10
KE - Kenya 10
NP - Nepal 10
RO - Romania 10
DO - Repubblica Dominicana 9
IL - Israele 9
JM - Giamaica 9
KZ - Kazakistan 9
KR - Corea 8
LB - Libano 8
DZ - Algeria 7
HN - Honduras 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
PA - Panama 7
PS - Palestinian Territory 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
AM - Armenia 6
CR - Costa Rica 6
AU - Australia 5
CH - Svizzera 5
GT - Guatemala 5
LK - Sri Lanka 5
MD - Moldavia 5
NI - Nicaragua 5
SN - Senegal 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
ET - Etiopia 4
GE - Georgia 4
HU - Ungheria 4
IS - Islanda 4
LU - Lussemburgo 4
RS - Serbia 4
TH - Thailandia 4
AO - Angola 3
BH - Bahrain 3
CY - Cipro 3
DK - Danimarca 3
EE - Estonia 3
KW - Kuwait 3
Totale 42.333
Salva come PNG Salva come JPEG
Città #
Dallas 10.077
Moscow 2.023
Dublin 1.567
Singapore 1.552
Ashburn 1.501
Chandler 1.189
Jacksonville 1.140
Nyköping 862
Beijing 617
Hong Kong 600
San Jose 524
Dong Ket 358
Los Angeles 311
The Dalles 256
Princeton 254
Dearborn 244
Lauterbourg 228
Cambridge 215
Medford 210
Des Moines 189
Messina 180
Ann Arbor 158
Boardman 150
Hyderabad 125
São Paulo 121
Buffalo 117
New York 114
Munich 109
Ho Chi Minh City 107
Council Bluffs 91
Woodbridge 89
Lancaster 86
Hanoi 78
Guangzhou 72
Wilmington 69
Tianjin 68
Pune 64
Orem 62
Warsaw 56
Redondo Beach 55
Brussels 53
Frankfurt am Main 53
San Mateo 53
Santa Clara 52
Turku 52
Brooklyn 51
Belo Horizonte 50
Jinan 50
Seattle 50
Tokyo 49
Milan 48
Rio de Janeiro 48
Brno 43
Vienna 42
Shenyang 41
Denver 40
Catania 39
Chicago 39
Houston 38
Tashkent 38
London 37
Johannesburg 36
Montreal 36
Atlanta 35
Phoenix 35
Brasília 34
Abidjan 33
Amsterdam 33
Rome 33
Nanjing 31
Baghdad 30
Shanghai 29
Stockholm 29
Chennai 28
Haikou 28
Helsinki 28
Curitiba 27
Manchester 26
Nuremberg 26
Toronto 25
Washington 25
Porto Alegre 24
Hangzhou 21
Poplar 21
Taizhou 21
Zhengzhou 21
Guayaquil 20
San Francisco 20
Boston 19
Dhaka 19
Düsseldorf 19
Fuzhou 19
Lappeenranta 19
Ningbo 19
Ottawa 18
Ribeirão Preto 18
Fortaleza 17
Francofonte 17
Goiânia 17
Nanchang 17
Totale 27.827
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.729
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.709
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 298
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 270
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 268
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 256
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 256
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 222
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 216
4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one 211
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 210
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 203
AMPA receptor antagonists: Synthesis and pharmacological evaluation 203
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 200
Anticonvulsant agent: enhancement of physicochemical properties 199
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 199
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 198
5-Phenyl-9H-1,3-dioxolo[4,5-h][2,3]-benzodiazepin-8(7H)-one 196
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 192
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 190
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 190
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 190
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 190
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS 190
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinase 188
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 187
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 186
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 183
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 182
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 182
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 181
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 181
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 181
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 180
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 179
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 178
Design and synthesis of acetylcholinesterase inhibitors 177
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 176
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 172
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 172
2,3-Benzodiazepines as potential AMPA receptors antagonists 170
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 168
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 166
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 166
Analysis of structure-activity relationships in a series of 4-(1-piperazinyl)phenol-based derivatives as competitive inhibitors of Tyrosinase 166
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 165
Antiretroviral strategy using multi-target agents 164
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 163
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 163
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 162
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 161
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 161
Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae 160
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 160
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 160
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 160
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 160
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 158
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 158
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 157
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 157
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 156
Design, synthesis and in vitro evaluation of 4-fluorobenzyl- and 4-hydroxyphenyl-based compounds targeting tyrosinases 156
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 154
Leveraging the 3-Chloro-4-fluorophenyl Motif to Identify Inhibitors of Tyrosinase from Agaricus bisporus 153
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 153
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 153
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 153
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 152
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 152
Binding modes of noncompetitive AMPA antagonists: a computational approach 151
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 151
Annelated 1,5-benzothiazepines 151
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 150
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 149
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 148
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 148
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 148
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 147
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 147
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 146
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 145
ELECTRONIC-PROPERTIES OF THIENODIAZEPINE AND BENZODIAZEPINE DERIVATIVES 144
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 144
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 143
Searching for alpha-syn inhibitors to fight Parkinson’s disease 143
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation 142
Exploring the chemical space of 3-chloro-4-fluorophenyl-based compounds as tyrosinase inhibitors 142
Exploring the MUC1/CIN85 interaction to investigate a small library of peptide inhibitors as potential anti-metastatic agents 142
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 140
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 139
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 139
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 138
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 138
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 137
Discovery of a novel class of Tyrosinase inhibitors as antimelanogenic agents 136
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 135
Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. 135
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 135
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 133
Totale 26.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 0 0 0 0 0 0 0 452
2021/20221.596 38 201 32 66 64 30 135 59 38 79 320 534
2022/20234.717 368 418 208 423 348 464 94 242 1.912 16 168 56
2023/20241.343 94 189 81 253 107 235 20 64 5 155 23 117
2024/20255.302 83 103 124 311 248 150 149 1.203 1.297 318 493 823
2025/202624.682 733 3.519 7.511 1.313 1.281 3.676 1.817 1.959 1.875 599 244 155
Totale 42.730